| 1 |
33546058 | Hypertension in a patient with medullary sponge kidney: A case report. | 2021 Jan 22 |
1 |
| 2 |
34013341 | Serum potassium changes due to concomitant ACEI/ARB and spironolactone therapy: A systematic review and meta-analysis. | 2021 Dec 9 |
1 |
| 3 |
34522111 | Effect of Angiotensin Receptor Blocker and Angiotensin Converting Enzyme Inhibitor on Kidney Function and Blood Potassium Level in Indonesian Type 2 Diabetes Mellitus with Hypertension: A Three-Month Cohort Study. | 2021 |
1 |
| 4 |
32016907 | Hypokalemia and hyperkalemia in patients on peritoneal dialysis: incidence and associated factors. | 2020 Feb |
1 |
| 5 |
31498767 | ACE inhibitors and ARBs: Managing potassium and renal function. | 2019 Sep |
1 |
| 6 |
28177101 | [Severe hyperkalemia in patients referred to an emergency departement: the role of antialdosterone drugs and of renin-angiotensin system blockers]. | 2017 Jan-Feb |
1 |
| 7 |
28575882 | Relationship Between Angiotensin-converting Enzyme Gene Polymorphism and QT Dispersion in Hemodialysis Patients. | 2017 May |
1 |
| 8 |
25683504 | Risk of hyperkalemia and combined use of spironolactone and long-term ACE inhibitor/angiotensin receptor blocker therapy in heart failure using real-life data: a population- and insurance-based cohort. | 2015 Apr |
1 |
| 9 |
24869750 | Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension. | 2014 May 29 |
1 |
| 10 |
23898345 | A Rare Case of Type I RenalTubular Acidosis with Membranous Nephropathy Presenting as Hypokalemic Paralysis. | 2013 Jun |
1 |
| 11 |
20112435 | Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril. | 2010 Mar |
1 |
| 12 |
18234845 | ACE-inhibitor or AT2-antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrations. | 2008 May |
1 |
| 13 |
18307835 | Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis. | 2008 Apr |
1 |
| 14 |
18468748 | Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression. | 2008 Sep |
2 |
| 15 |
19124424 | ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET. | 2008 Aug |
1 |
| 16 |
17845569 | Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence. | 2007 Oct |
1 |
| 17 |
18058481 | Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment. | 2007 Nov |
1 |
| 18 |
16450155 | Hydrochlorothiazide efficacy and polymorphisms in ACE, ADD1 and GNB3 in healthy, male volunteers. | 2006 Mar |
1 |
| 19 |
16797382 | Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data. | 2006 Jul |
1 |
| 20 |
15662077 | Life threatening hyperkalaemia with diarrhoea during ACE inhibition. | 2005 Feb |
1 |
| 21 |
15946459 | Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis. | 2005 May |
1 |
| 22 |
15017529 | Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease: safety issues. | 2004 Mar |
1 |
| 23 |
15051858 | Hypotensive peptides from milk proteins. | 2004 Apr |
1 |
| 24 |
15384026 | Effects of an ACE inhibitor or angiotensin receptor blocker on potassium in CAPD patients. | 2004 Oct |
1 |
| 25 |
12552520 | Ace inhibitors and survival in dialysis patients: effects on serum potassium? | 2003 Feb |
1 |
| 26 |
11959039 | Influence of progressive renal dysfunction in chronic heart failure. | 2002 Mar |
1 |
| 27 |
11975043 | [Malignant arrhythmias caused by hyperkalemia: a new area of drug-induced electrolyte abnormalities]. | 2002 Mar 31 |
2 |
| 28 |
12092742 | Comparative effects on dynamic renal potassium excretion of ACE inhibition versus angiotensin receptor blockade in hypertensive patients with type II diabetes mellitus. | 2002 Jul |
1 |
| 29 |
12136480 | [Use of angiotensin-converting enzyme inhibitors in chronic kidney insufficiency]. | 2002 |
1 |
| 30 |
11328912 | The effect of ACE inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with CsA. | 2001 May |
1 |
| 31 |
11331054 | Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases. | 2001 Apr 15 |
1 |
| 32 |
10652037 | Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. | 2000 Feb |
1 |
| 33 |
10921262 | [The side effects of angiotensin-converting enzyme inhibitors in the treatment of arterial hypertension]. | 2000 Apr-Jun |
1 |
| 34 |
11044229 | ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group. | 2000 Nov |
1 |
| 35 |
10070908 | A subdepressor low dose of ramipril lowers urinary protein excretion without increasing plasma potassium. | 1999 Mar |
1 |
| 36 |
10619572 | Are drugs that block the renin-angiotensin system effective and safe in patients with renal insufficiency? | 1999 Dec |
1 |
| 37 |
9437375 | Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry? | 1998 Jan 12 |
1 |
| 38 |
9000551 | Renal failure related to angiotensin-converting enzyme inhibitors. | 1997 Jan |
1 |
| 39 |
9198848 | [Pharmacology of potassium-sparing diuretics]. | 1997 Apr 2 |
1 |
| 40 |
9360571 | Rapid life-threatening hyperkalemia after addition of amiloride HCl/hydrochlorothiazide to angiotensin-converting enzyme inhibitor therapy. | 1997 Nov |
3 |
| 41 |
9534323 | [The influence of ACE inhibitors on urinary electrolyte secretion and the response to transitory hypovolemia in chronic heart failure]. | 1997 Dec |
1 |
| 42 |
8760660 | [Treatment of cardiac failure with angiotensin-converting enzyme inhibitors and diuretics]. | 1996 Jun |
1 |
| 43 |
9070382 | Cardioprotective potential of angiotensin converting enzyme inhibitors. | 1996 Jun |
1 |
| 44 |
7562882 | Lisinopril administration improves insulin action in aged patients with hypertension. | 1995 Jul |
1 |
| 45 |
7589016 | Four week administration of an ACE inhibitor and a cardioselective beta-blocker in healthy volunteers: no influence on insulin sensitivity. | 1995 Aug |
1 |
| 46 |
7629980 | Diet and serum potassium in patients on ACE inhibitors. | 1995 Aug 16 |
1 |
| 47 |
7669262 | ACE inhibitors. Drug interactions of clinical significance. | 1995 May |
1 |
| 48 |
7751417 | Selected aspects of ACE inhibitor therapy for patients with renal disease: impact on proteinuria, lipids and potassium. | 1995 Jan |
1 |
| 49 |
7526050 | Safety of concomitant potassium-sparing diuretics in angiotensin-converting enzyme inhibitor therapy in severe congestive heart failure. Xamoterol in Severe Heart Failure Study Group. | 1994 Aug |
1 |
| 50 |
8070497 | OACE inhibition does not interfere with acute extrarenal or renal potassium disposal in chronic renal failure. | 1994 |
1 |